Chemo-Pharma Laboratories Ltd.
Snapshot View

40.70 -2.10 ▼-4.9%

23 September 2022, 04:01:00 PM
Volume: 252

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.thechemopharmalaboratoriesltd.com
Market Cap 6.11 Cr.
Enterprise Value(EV) -0.08 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.19 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 210.52 Trailing Twelve Months Ending 2022-06
Industry PE 30.97 Trailing Twelve Months Ending 2022-06
Book Value / Share 73.69 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.55 Calculated using Price: 40.70
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.15 Cr. 1,500,000 Shares
FaceValue 10
Company Profile
Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.91%
1 Week
-8.74%
1 Month
+20.77%
3 Month
+25.23%
6 Month
+2.26%
1 Year
+62.80%
2 Year
+126.49%
5 Year
+8.53%
10 Year
+56.54%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.10 5.61 4.15 60.99 1.00 2.02 3.94 2.30 4.97
Return on Capital Employed (%) 6.22 7.52 5.96 68.41 7.54 2.50 4.69 2.86 3.24
Return on Assets (%) 4.79 5.20 3.90 57.64 0.96 2.00 3.88 2.27 4.99

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 5 5 5 5 10 10 10 11 11 12
Non Curr. Liab. 0 0 0 0 0 0
Curr. Liab. 0 0 0 0 1 0 0 0 0 0
Minority Int.
Equity & Liab. 5 5 6 6 11 10 10 11 11 11
Non Curr. Assets 3 4 3 3 2 2 2 2 0 5
Curr. Assets 2 2 2 2 9 9 9 9 11 6
Misc. Exp. not W/O
Total Assets 5 5 6 6 11 10 10 11 11 11

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales
Other Income 0 1 0 6 1 1 1 1 1 0
Total Income 0 1 0 6 1 1 1 1 1 0
Total Expenditure 0 0 0 0 0 -1 0 0 0 0
PBIDT 0 0 0 5 1 0 1 0 0 0
Interest
Depreciation 0 0 0 0
Taxation 0 0 0 -1 -1 0 0 0 0 0
Exceptional Items
PAT 0 0 0 5 0 0 0 0 1 0
Adjusted EPS 2 2 1 31 1 1 3 2 4 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 6 -2 -5 5 0 0
Cash Fr. Inv. 0 0 0 0 1 1 1 1 0 1
Cash Fr. Finan. -1 1 2 -2
Net Change 0 0 0 0 6 1 -5 6 1 -1
Cash & Cash Eqvt 0 0 0 0 7 8 3 9 2 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 27.89 27.89 27.89 27.89 27.89 27.89 27.89 27.89 27.89
Public 72.11 72.11 72.11 72.11 72.11 72.11 72.11 72.11 72.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 10 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizers Report of the 80TH Annual General Meeting as per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) 2015
Sat, 10 Sep 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Chemo Pharma Laboratories Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here
Thu, 08 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings/Outcome of the 80th Annual General Meeting as per Regulation 30 Read With Schedule III of SEBI (Listing Obligations and Disclosure Requirements) 2015

Technical Scans View Details >>

Fri, 23 Sep 2022
Opening at High Opening at High
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,930.76 920.80 +1.5%
Divi's Laboratories Ltd. 96,681.00 3,641.90 +1.7%
Cipla Ltd. 86,429.87 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. 68,908.63 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. 63,570.07 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. 51,257.56 1,514.50 -1.6%
Max Healthcare Institute Ltd. 41,385.83 426.80 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.80 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.13 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 34.73 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.04 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.96 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.99 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 65.59 426.80 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.41 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.78 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 4.02 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.70 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.02 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.43 426.80 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 426.80 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 426.80 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 426.80 -0.1%

FAQ's On Chemo-Pharma Laboratories Ltd.

What is Chemo Pharma Labs share price?

Can I buy Chemo Pharma Labs shares now?

What is the Market Cap of Chemo Pharma Labs?

What are the key metrics to analyse Chemo Pharma Labs?

What is the 52 Week High and Low of Chemo Pharma Labs?

What is the trend of Chemo Pharma Labs share price?